Researchers discover new bacterial compounds with potential for cancer drug development

Researchers at the Helmholtz Center for Infection Research and the Helmholtz Institute for Pharmaceutical Research Saarland have identified a new family of natural compounds produced by microorganisms. They have clarified the unique biosynthesis of these compounds and developed synthetic production methods, highlighting their potential as future cancer drugs.

Originally published by gnews